Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Oct 3, 2016
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called SEA-HD, aims to create a local database and DNA bank specifically for children with congenital heart defects in the south-eastern region of France. Congenital heart defects are heart problems that are present at birth, affecting about 5,000 newborns each year in France. Understanding the genetic causes of these defects is important, but currently, there isn’t a local facility to collect and study the required DNA samples. By setting up this local DNA bank, researchers hope to gain better insights into the genetic factors that contribute to these conditions.
To participate in this study, children must have a diagnosed congenital heart defect as determined by an echocardiogram (a special heart ultrasound) and need to have a blood test as part of their usual medical care at the AP-HM Timone Hospital in Marseille. However, pregnant women, individuals who cannot understand or provide consent, and certain other groups are not eligible. If your child participates, they will be contributing to a valuable resource that could help improve our understanding of congenital heart diseases, potentially benefiting future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Echocardiographic diagnosis of congenital heart defect falling within the classification Houyel and Bonnet
- • Necessity of making a blood test regardless of study
- • Medical care in the AP-HM Timone Hospital children, medical-surgical unit of pediatric and congenital cardiology, Marseille - These Parent Child
- Exclusion Criteria:
- • Pregnant women
- • Patients or parent / legal guardian (if minor) in physical or mental incapacity to understand or sign the consent
- • People in Emergencies
- • Persons deprived of freedom
- • Persons not beneficiaries of a social security scheme
- • Persons in health or social institution
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Patients applied
Trial Officials
catherine GEINDRE
Study Director
ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials